Award

WJWRC202306

Funder: Shanghai Municipal Health Commission

Funded outputs count: 3

Funder award ID: WJWRC202306

OpenAlex ID: G2503322154

ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition

2026 · Li-Ping Ge, Yu-Ling Xiao, et al. · Nature Communications

Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer

2026 · Xiang-Rong Wu, Hong Lv, et al. · Signal Transduction and Targeted Therapy · 3

Age-related B cell dysfunction at the aging-cancer nexus: from shared manifestations to therapeutic potential

2026 · Luo-Tian Liu, Han Wang, et al. · Cancer Letters · 1